REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab
Clinical trial NCT02688998 · COMPLETED
Trial details
- NCT number
- NCT02688998
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.